Intriguingly, it has been reported that CDK4/6 inhibitors not only suppress tumor cell growth by inducing cell cycle arrest, they also trigger tumor immune evasion through inhibition of cullin 3–SPOP E3 ligase-mediated proteasomal degradation of PD-L1 that increases the abundance of the protein33. The gene discussed is CDK4; the disease is neoplasm.